Elizabeth "Liz" Whalley Buono, RN, J.D., joined the MCV Foundation board in 2013.
Liz is the lead partner in the Life Sciences practice group at Hancock Daniel. She focuses her practice on clinical research, pharmacy compounding, privacy, FDA regulated products, fraud and abuse, healthcare innovation and new product development.
Liz began her legal career in 2001 at Wiley, Rein and Fielding LLP in Washington, D.C. where practiced FDA and privacy law. Prior to practicing law, she had careers as a medical/surgical and psychiatric nurse in the Boston area and had an extensive 13-year tenure in the pharmaceutical industry with Parke-Davis/Warner Lambert and Pfizer. In 2003, Liz joined Altria Client Services as senior counsel, managing the legal and health ethics considerations associated with tobacco harm reduction. In 2009, Liz moved to WestRock Healthcare as V.P. for global quality, regulatory and external affairs and general counsel of the company’s healthcare division, with primary responsibility for the company’s drug, device, pharmacy and patient medication adherence products and services.
More recently, through her private consultancy, Liz supports healthcare innovation efforts undertaken by, among others, the Bill and Melinda Gates Foundation. She currently serves on the FDA Working Group to Enhance Opioid Safety and the CDC PROTECT Initiative.
Liz received her B.S.N. from Boston College School of Nursing and earned her M.B.A. in executive management from St. John’s University College of Business Administration. She received her J.D. in health law and economics from George Mason University.